An abrupt and unexpected increase in pump thrombosis has occurred since March 2011 in patients with advanced heart failure who received the HeartMate II left ventricular assist device, according to a...
The American Heart Association has set aside a 5-year, $30-million research fund to dig deeper into two large national studies in hopes of finding more clues to personalized treatment and prevention...
DALLAS – An EDTA-based chelation regimen for secondary prevention of cardiovascular events in patients with a history of myocardial infarction got a boost from a new TACT trial analysis showing...
The telltale traits of acute myocardial infarction–associated chest pain may differ in women and men, but they aren’t diagnostically telling enough to determine which women with chest pain are having...
DALLAS – Enhanced pacemaker technology sharply reduced progression of nonpermanent atrial fibrillation to permanent AF in patients with bradycardia and sinus node disease in the large international,...
SAN FRANCISCO – A noninvasive test that computes fractional flow reserve from coronary CT angiography images was highly accurate in detecting ischemia, compared with anatomic interpretation from CT...
Dr. Donald Lloyd-Jones, co-chair of the guidelines work group, speaks about the risk calculator and why physicians should still consider incorporating the guidelines into their practice.
<iframe...
DALLAS – In the face of high-profile criticism of the new U.S. cholesterol-management guidelines released by the American College of Cardiology and American Heart Association on Nov. 12, the...
Two doses of the once-daily, oral factor Xa inhibitor edoxaban were noninferior to warfarin in preventing stroke or systemic embolism in patients with atrial fibrillation in the phase III ENGAGE...
The cholesterol guideline represents a major change for several reasons. Unlike any previous guidelines in the United States or elsewhere, the cholesterol guideline is truly process oriented and...
